Radialis Inc

Purpose

Radialis has developed a groundbreaking versatile organ-targeted PET platform with the assistance of IRAP. The system has been cleared by the FDA for the broad indication of visualizing and quantifying radiotracer. Now that the platform has been prepared, there are clinical requirements of particular applications in breast, brain, and torso imaging that still present technical challenges. This project will leverage the prior success developing a PET platform to address particular challenges in biopsy guidance, range of motion, field of view, 3D imaging, and generative neural network image enhancement.